Safety and performance of an advanced hybrid closed-loop algorithm with ultra rapid lispro and lispro

被引：0
|
作者：
Pollom, R. K. [1 ]
Nosek, L. [2 ]
Coester, H. Veir [2 ]
Zijlstra, E. [2 ]
Ghosh, A. [1 ]
Haidar, A. [3 ]
Jones, R. E. [1 ]
Leohr, J. K. [1 ]
Gleissner, S. E. [1 ]
Dassau, E. [1 ]
Katz, M. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Profil, Neuss, Germany
[3] McGill Univ, Montreal, PQ, Canada
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
770
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [1] Safety and Performance of an Advanced Hybrid Closed-Loop (AHCL) Algorithm with Ultra-rapid Lispro (URLi) and Lispro
    Pollom, Robyn K.
    Nosek, Leszek
    Coester, Hans Veit
    Zijlstra, Eric
    Ghosh, Aritra
    Haidar, Ahmad
    Jones, Richard
    Leohr, Jennifer
    Gleissner, Stephanie E.
    Dassau, Eyal
    Katz, Michelle
    DIABETES, 2023, 72
  • [2] Adjusting Therapy Profiles When Switching to Ultra-Rapid Lispro in an Advanced Hybrid Closed-Loop System: An in Silico Study
    Colmegna, Patricio
    Diaz, C. Jenny L.
    Garcia-Tirado, Jose
    DeBoer, Mark D.
    Breton, Marc D.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2024, 18 (03): : 676 - 685
  • [3] Ultrarapid Lispro Demonstrates Similar Time in Target Range to Lispro with a Hybrid Closed-Loop System
    Bode, Bruce
    Carlson, Anders
    Liu, Rong
    Hardy, Thomas
    Bergenstal, Richard
    Boyd, Jennifer
    Morrett, Scott
    Ignaut, Debra
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (12) : 828 - 836
  • [4] ULTRA RAPID LISPRO (URLI) DEMONSTRATES SIMILAR TIME IN TARGET RANGE TO LISPRO WITH THE MEDTRONIC MINIMED 670G HYBRID CLOSED-LOOP SYSTEM
    Carlson, A.
    Liu, R.
    Hardy, T.
    Boyd, J.
    Bergenstal, R.
    Morrett, S.
    Ignaut, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A85 - A86
  • [5] Ultra Rapid Lispro (URLi) demonstrates similar time in target range to Lispro with the Medtronic MiniMed 670G hybrid closed-loop system
    Bode, B.
    Carlson, A.
    Liu, R.
    Hardy, T.
    Boyd, J.
    Bergenstal, R.
    Morrett, S.
    Ignaut, D.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S327 - S327
  • [6] CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro Compared with Standard Lispro in Adults with Type 1 Diabetes: A Double-Blind, Randomized, Crossover Study
    Nwokolo, Munachiso
    Lakshman, Rama
    Hartnell, Sara
    Alwan, Heba
    Ware, Julia
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Evans, Mark L.
    Hovorka, Roman
    Boughton, Charlotte K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (12) : 856 - 863
  • [7] Pediatric safety and glycemic outcomes using the MiniMed™ 780g advanced hybrid closed-loop (aHCL) system with ultra-rapid insulin lispro-aabc
    Forlenza, G.
    Nally, L.
    Shulman, D.
    Demeterco-Berggren, C.
    Reiner, B.
    Kudva, Y.
    Bode, B.
    Dewan, A.
    Kipnes, M.
    Niu, F.
    Yovanovich, C.
    Shin, J.
    Cordero, T.
    McVean, J.
    Rhinehart, A.
    Vigersky, R.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 311 - 311
  • [8] Hybrid closed-loop with ultra-rapid insulin lispro increases time in range compared with standard insulin lispro in adults with type 1 diabetes: a randomised crossover study
    Lakshman, R.
    Nwokolo, M.
    Boughton, C. K.
    Ware, J.
    Allen, J. M.
    Wilinska, M. E.
    Alwan, H.
    Evans, M. L.
    Hovorka, R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S388 - S389
  • [9] Efficacy and safety of ultra-rapid lispro compared to insulin lispro in adults with type 1 diabetes
    Zhou, Z.
    Ma, J.
    Lei, T.
    An, Z.
    Xue, Y.
    Manghi, F. P.
    Garcia, P.
    Xu, J.
    Yuan, Y.
    Yan, X.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S364 - S364
  • [10] CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Insulin Lispro Increases Time in Range Compared with Standard Insulin Lispro in Adults with Type 1 Diabetes-A Double-Blind, Randomized, Crossover Study
    Nwokolo, Munachiso
    Lakshman, Rama
    Boughton, Charlotte K.
    Ware, Julia
    Allen, Janet M.
    Wilinska, Malgorzata E.
    Alwan, Heba
    Evans, Mark
    Hovorka, Roman
    DIABETES, 2023, 72
12345